BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9291505)

  • 1. Fumonisin B1 in developing rats alters brain sphinganine levels and myelination.
    Kwon OS; Schmued LC; Slikker W
    Neurotoxicology; 1997; 18(2):571-79. PubMed ID: 9291505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fumonisin B1 treatment on blood-brain barrier transfer in developing rats.
    Kwon OS; Sandberg JA; Slikker W
    Neurotoxicol Teratol; 1997; 19(2):151-5. PubMed ID: 9136132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of sphinganine, sphingosine and Sa/So ratio in urine of humans exposed to dietary fumonisin B1.
    Qiu M; Liu X
    Food Addit Contam; 2001 Mar; 18(3):263-9. PubMed ID: 11304035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of sphingolipid biosynthesis in rat primary hepatocyte cultures by fumonisin B1 and other structurally related compounds.
    van der Westhuizen L; Shephard GS; Snyman SD; Abel S; Swanevelder S; Gelderblom WC
    Food Chem Toxicol; 1998 Jun; 36(6):497-503. PubMed ID: 9674957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of apoptosis by fumonisin B1 in HT29 cells is mediated by the accumulation of endogenous free sphingoid bases.
    Schmelz EM; Dombrink-Kurtzman MA; Roberts PC; Kozutsumi Y; Kawasaki T; Merrill AH
    Toxicol Appl Pharmacol; 1998 Feb; 148(2):252-60. PubMed ID: 9473533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The induction and persistence of altered sphingolipid biosynthesis in rats treated with fumonisin B1.
    Garren L; Galendo D; Wild CP; Castegnaro M
    Food Addit Contam; 2001 Sep; 18(9):850-6. PubMed ID: 11552753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal fumonisin (FB1) treatment in rats results in minimal maternal or offspring toxicity.
    Ferguson SA; Omer VE; Kwon OS; Holson RR; Houston RJ; Rottinghaus GE; Slikker W
    Neurotoxicology; 1997; 18(2):561-9. PubMed ID: 9291504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinutritional effects of fumonisin B1 and pathophysiological consequences.
    Carratù MR; Cassano T; Coluccia A; Borracci P; Cuomo V
    Toxicol Lett; 2003 Apr; 140-141():459-63. PubMed ID: 12676494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of sphinganine 1-phosphate as a predictive biomarker for fumonisin exposure and toxicity in mice.
    Kim DH; Yoo HS; Lee YM; Kie JH; Jang S; Oh S
    J Toxicol Environ Health A; 2006 Dec; 69(23):2071-82. PubMed ID: 17060094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analytical method for the determination of sphinganine and sphingosine in serum as a potential biomarker for fumonisin exposure.
    Castegnaro M; Garren L; Galendo D; Gelderblom WC; Chelule P; Dutton MF; Wild CP
    J Chromatogr B Biomed Sci Appl; 1998 Dec; 720(1-2):15-24. PubMed ID: 9892062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fumonisin B1 consumption by rats causes reversible, dose-dependent increases in urinary sphinganine and sphingosine.
    Wang E; Riley RT; Meredith FI; Merrill AH
    J Nutr; 1999 Jan; 129(1):214-20. PubMed ID: 9915902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of fumonisin B1 in pregnant rats. Part 2.
    Collins TF; Sprando RL; Black TN; Shackelford ME; Laborde JB; Hansen DK; Eppley RM; Trucksess MW; Howard PC; Bryant MA; Ruggles DI; Olejnik N; Rorie JI
    Food Chem Toxicol; 1998 Aug; 36(8):673-85. PubMed ID: 9734718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender-related differences in subacute fumonisin B1 hepatotoxicity in BALB/c mice.
    Bhandari N; He Q; Sharma RP
    Toxicology; 2001 Aug; 165(2-3):195-204. PubMed ID: 11522378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fumonisin B1 alters sphingolipid metabolism and disrupts the barrier function of endothelial cells in culture.
    Ramasamy S; Wang E; Hennig B; Merrill AH
    Toxicol Appl Pharmacol; 1995 Aug; 133(2):343-8. PubMed ID: 7645031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of fumonisin B1-contaminated feeds on weanling angora goats.
    Gurung NK; Rankins DL; Shelby RA; Goel S
    J Anim Sci; 1998 Nov; 76(11):2863-70. PubMed ID: 9856397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fumonisin B1 in pregnant rats.
    Collins TF; Shackelford ME; Sprando RL; Black TN; Láborde JB; Hansen DK; Eppley RM; Trucksess MW; Howard PC; Bryant MA; Ruggles DI; Olejnik N; Rorie JI
    Food Chem Toxicol; 1998 May; 36(5):397-408. PubMed ID: 9662415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary fumonisins disrupt sphingolipid metabolism in mink and increase the free sphinganine to sphingosine ratio in urine but not in hair.
    Morgan MK; Schroeder JJ; Rottinghaus GE; Powell DC; Bursian SJ; Aulerich RJ
    Vet Hum Toxicol; 1997 Dec; 39(6):334-6. PubMed ID: 9397500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The naturally occurring food mycotoxin fumonisin B1 impairs myelin formation in aggregating brain cell culture.
    Monnet-Tschudi F; Zurich MG; Sorg O; Matthieu JM; Honegger P; Schilter B
    Neurotoxicology; 1999 Feb; 20(1):41-8. PubMed ID: 10091857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical and morphological effects of fumonisin B(1) on primary cultures of rat cerebrum.
    Kwon OS; Slikker W; Davies DL
    Neurotoxicol Teratol; 2000; 22(4):565-72. PubMed ID: 10974595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum sphinganine and the sphinganine to sphingosine ratio as a biomarker of dietary fumonisins during chronic exposure in ducks.
    Tran ST; Tardieu D; Auvergne A; Bailly JD; Babilé R; Durand S; Benard G; Guerre P
    Chem Biol Interact; 2006 Mar; 160(1):41-50. PubMed ID: 16413517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.